NN304-4528: Retrospective Cohort study of all-Cause and Cardiovascular Mortality in type 2 diabetes patients using basal insulin Detemir and GlargineFirst published 14/05/2019 Last updated 14/03/2024 EU PAS number: EUPAS29708StudyFinalised
Clinical Reporting Anchor and Disclosure (1452) Novo Nordisk A/SStudy contactpactadmin@novonordisk.com